Cargando…
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
Liver steatosis is a common characteristic of obesity and type 2 diabetes, and fatty liver disease is increasingly recognized as a major health burden. Accumulating evidence suggests that β-glycosphingolipids play an important role in insulin sensitivity and thus could affect hepatic steatosis. To d...
Autores principales: | Zigmond, Ehud, Tayer-Shifman, Oshrat, Lalazar, Gadi, Ben Ya’acov, Ami, Weksler-Zangen, Sarah, Shasha, David, Sklair-Levy, Miriam, Zolotarov, Lidya, Shalev, Zvi, Kalman, Rony, Ziv, Ehud, Raz, Itamar, Ilan, Yaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200037/ https://www.ncbi.nlm.nih.gov/pubmed/25336983 http://dx.doi.org/10.2147/JIR.S50508 |
Ejemplares similares
-
Protein Tyrosine Phosphatase Activity in Insulin-Resistant Rodent Psammomys Obesus
por: Meyerovitch, Joseph, et al.
Publicado: (2002) -
Protein Tyrosine Phosphatase 1B is Impaired in Skeletal Muscle of Diabetic Psammomys Obesus
por: Ikeda, Yukio, et al.
Publicado: (2002) -
A high oleic sunflower oil fatty acid esters of plant sterols mixed with dietary diacylglycerol reduces plasma insulin and body fat accumulation in Psammomys obesus
por: Ziv, Ehud, et al.
Publicado: (2009) -
Psammomys obesus, a particularly important animal model for the study of the human diabetic nephropathy
por: Scherzer, Pnina, et al.
Publicado: (2011) -
Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury
por: Mizrahi, Meir, et al.
Publicado: (2018)